Topic: drug plan design

Panel: Should drug coverage for certain conditions still be optional?

Martha Porado | June 14, 2019 / News

How changing public coverage could affect the pharmaceuticals industry

Martha Porado | June 14, 2019 / News

The potential effects of public drug plan changes on new therapies in Canada

Martha Porado | June 7, 2019 / News

The legal risks of drug plan design changes

Sara Tatelman | May 10, 2019 / News